尽管林业发展局不予批准,但40岁和50岁的妇女越来越多地寻求睾丸激素以治疗症状。 Women in their 40s and 50s increasingly seek testosterone for symptoms, despite FDA non-approval.
在社交媒体影响者和远程医疗的推动下,40岁和50岁以上的妇女越来越多地寻求睾丸酮治疗,导致处方从2013年到2023年增加了近50%。 Women in their 40s and 50s are increasingly seeking testosterone therapy, driven by social media influencers and telemedicine, leading to a nearly 50% rise in prescriptions from 2013 to 2023. 正在寻找影响性欲、肌肉健康和能量的睾丸酮,以解决脑雾和低性动力等症状,尽管其给妇女带来的好处尚未得到充分证明。 Testosterone, which affects libido, muscle health, and energy, is being sought to address symptoms like brain fog and low sex drive, though its benefits for women are not fully proven. FDA 不批准女性使用睾酮疗法，但在排除其他原因后，医生可以开出治疗低下的处方。 The FDA does not approve testosterone therapy for women, but doctors can prescribe it for low libido after other causes are ruled out.